CXCR4.md
... ...
@@ -30,9 +30,9 @@ timeline
30 30
|Entity|Tier|Description |
31 31
|:------:|:----:|--------------------------------------|
32 32
|![MZL](images/icons/MZL_tier1.png)|1|high-confidence MZL gene|
33
-|![DLBCL](images/icons/DLBCL_tier1.png) |1-a | aSHM target and high-confidence DLBCL gene [@khodabakhshiRecurrentTargetsAberrant2012]|
34
-|![FL](images/icons/FL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in FL is tenuous [@krysiakRecurrentSomaticMutations2017b]|
35
-|![BL](images/icons/BL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in BL is tenuous [@paneaWholeGenomeLandscape2019]|
33
+|![DLBCL](images/icons/DLBCL_tier1.png) |1 | aSHM target and high-confidence DLBCL gene [@khodabakhshiRecurrentTargetsAberrant2012]|
34
+|![FL](images/icons/FL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in FL is tenuous [@krysiakRecurrentSomaticMutations2017b]|
35
+|![BL](images/icons/BL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in BL is tenuous [@paneaWholeGenomeLandscape2019]|
36 36
37 37
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
38 38